Covered recipient · General Payments record
RENEE BURKHART
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$670.22
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $277.09 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $81.45 | 5 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33.95 | 1 |
| Amgen Inc. | $32.90 | 2 |
| Lilly USA, LLC | $24.76 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.06 | 1 |
| Novo Nordisk AS | $19.03 | 1 |
| DEXCOM, INC. | $16.97 | 1 |
| Medtronic, Inc. | $15.45 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.25 | 1 |
| PFIZER INC. | $13.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.78 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106851463 | CMS |
| ABBVIE INC. | $18.40 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106851465 | CMS |
| ABBVIE INC. | $16.96 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106851467 | CMS |
| ABBVIE INC. | $16.94 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106851469 | CMS |
| ABBVIE INC. | $13.37 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106851471 | CMS |
| Amgen Inc. | $14.25 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117517480 | CMS |
| Amgen Inc. | $18.65 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117517482 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33.95 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117831982 | CMS |
| Dexcom, Inc. | $16.97 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153383482 | CMS |
| Lilly USA, LLC | $24.76 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135929612 | CMS |
| Medtronic, Inc. | $15.45 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116891999 | CMS |
| Novartis Pharmaceuticals Corporation | $24.06 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086624451 | CMS |
| Novo Nordisk Inc | $19.03 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100618076 | CMS |
| PFIZER INC. | $13.27 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132002745 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.25 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153484865 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.